Success Metrics

Clinical Success Rate
100.0%

Based on 8 completed trials

Completion Rate
100%(8/8)
Active Trials
1(11%)
Results Posted
75%(6 trials)

Phase Distribution

Ph phase_1
1
11%
Ph not_applicable
7
78%
Ph phase_3
1
11%

Phase Distribution

1

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution9 total trials
Phase 1Safety & dosage
1(11.1%)
Phase 3Large-scale testing
1(11.1%)
N/ANon-phased studies
7(77.8%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

8 of 8 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

9

all time

Status Distribution
Active(1)
Completed(8)

Detailed Status

Completed8
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
9
Active
1
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 11 (11.1%)
Phase 31 (11.1%)
N/A7 (77.8%)

Trials by Status

active_not_recruiting111%
completed889%

Recent Activity

Clinical Trials (9)

Drug Details

Intervention Type
BEHAVIORAL
Total Trials
9